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Abstract
Background: Adenosine to inosine (A-to-I) RNA-editing is an essential post-transcriptional mechanism that occurs
in numerous sites in the human transcriptome, mainly within Alu repeats. It has been shown to have consistent
levels of editing across individuals in a few targets in the human brain and altered in several human pathologies.
However, the variability across human individuals of editing levels in other tissues has not been studied so far.
Results: Here, we analyzed 32 skin samples, looking at A-to-I editing level in three genes within coding sequences
and in the Alu repeats of six different genes. We observed highly consistent editing levels across different
individuals as well as across tissues, not only in coding targets but, surprisingly, also in the non evolutionary
conserved Alu repeats.
Conclusions: Our findings suggest that A-to-I RNA-editing of Alu elements is a tightly regulated process and, as
such, might have been recruited in the course of primate evolution for post-transcriptional regulatory mechanisms.
Background
Site-selective adenosine to inosine (A-to-I) RNA-editing
is an essential post-transcriptional mechanism for
expanding the proteomic repertoire. It is carried out by
members of the double-stranded RNA-specific ADAR
family predominantly acting on precursor messenger
RNAs [1]. As inosines in mRNA are recognized as gua-
nosines (G) by the ribosome in the course of translation,
RNA-editing may lead to a codon exchange resulting in
a modified protein. ADAR-mediated RNA editing is
essential for the development and normal life of both
invertebrates and vertebrates [2-5]. Additionally, altered
editing patterns have been found to be associated with
various diseases including inflammation [6], SLE [7],
epilepsy [8], depression [9], ALS [10,11] and malignant
brain tumors such as gliomas and astrocytomas [12-14].
A-to-I editing affects numerous sites in the human tran-
scriptome, most of which are located in Alu elements
within untranslated regions [15-19]. Alu is a retrotran-
sposon, about 280 bp long, belonging to the class of
Short Interspersed Nuclear Elements (SINEs). More
than one million copies, are present in the human gen-
ome, comprising 10% of the whole genome mass [20].
The precise role of RNA editing in Alu r e p e a t si sy e ta
mystery. However, it might affect gene expression
through a number of mechanisms [21]: As inosine pairs
with cytosine, editing influence the stability of RNA
molecules by creating and disrupting secondary struc-
tures. At another level, since inosine is recognized as
guanosine by the splicing machinery A-I editing can
lead to modification of splice sites in introns, inducing
premature termination, frame-shift, or new exon forma-
tion [22,23].
Consistent levels of A-to-I RNA-editing across human
individuals were previously observed in a few recoding
sites, mainly glutamate receptors [10,12,24-26]. How-
ever, the variability of the editing level among different
human individuals has so far not been studied for
neither most recoding editing targets nor the abundant
Alu editing. Low variance of the editing level indicates a
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importance of the specific editing event.
To test this, we studied the variability in editing levels
across different human individuals and a variety of tis-
sues, genes and sites.
Results and Discussion
Editing levels are consistent among skin samples of
human individuals both in coding and non-coding
sequences
In healthy brain tissue, editing levels for the recoding
sites within the glutamate receptor are highly uniform
across individuals [10,12,24]. As a first step, we tested
whether the same is true for other editing sites occur-
ring within coding sequences expressed in other tissues.
First, we investigated 32 skin samples. Although mice
ADAR1 or ADAR2 knockout die in-utero or shortly
after birth, RNA editing is implicated as relevant to the
skin in humans by the observation that mutations in
ADAR1 lead to Dyschromatosis symmetrica hereditaria
[27], a pigmenting genodermatosis with an autosomal
dominant inheritance reported predominantly in Japa-
nese and Chinese individuals [28]. It is interesting to
note that the effect of these mutations on ADAR1 func-
tion or editing pattern has not been found.
We looked at A-to-I editing levels in three recently
discovered, mouse-conserved, targets within coding
sequences: FLNA, CYFIP2 and BLCAP [29,30]. Filamin
A (FLNA) displays an A®I editing site in its transcript
(chromosome X:153,233,144, edited by both ADAR1
and ADAR2 [31] ), resulting in a Q®R substitution at
amino acid 2341 in the human protein. The CYFIP2
(cytoplasmic FMR1 interacting protein 2) transcript
encodes a protein of 1253 amino acids, and undergoes
A®I editing (by ADAR2 [31]) at chromosome
5:156,669,386, resulting in K®E substitution at amino
acid 320. BLCAP (bladder cancer associated protein), is
highly conserved among species, having 91% and 100%
identity at the DNA (coding region) and protein levels,
and is recoded by editing. Here, we tested one editing
site in the nucleotide encoding the second codon of
BLCAP, located at chromosome 20:35,580,986, resulting
in a Y®C substitution. Sequenome analysis for RNA
editing [32] has shown an average editing level of 8, 9
and 14% for FLNA, CYFIP2 and BLCAP, respectively, in
the skin samples. Remarkably, in all three genes, we
observed a comparable level of editing for the 32 indivi-
duals, as mirrored by the low standard deviations - in
all three sites the standard-deviation of the editing levels
across individuals is about 1/3 of their averaged editing
level (standard deviations were 2.7, 3 and 4.2 for FLNA,
CYFIP2 and BLCAP, respectively, where editing levels
are measured on a 0-100 scale as usual; see Figure 1A).
These finding suggested that the protein diversity
derived from editing is tightly regulated in these targets.
Editing levels of FLNA and CYFIP2 in skin were lower
than the values reported for normal brain tissue, while
i nB L C A P ,t h el e v e lw a sc o m p a r a b l et ot h eo n ei nn o r -
mal brain tissue, oral cavity and lung [13]. This observa-
tion is consistent with previous reports suggesting that
BLCAP is edited (almost) only by ADAR1, while the
other two sites are edited by both ADARs or by ADAR2
alone [31].
Next, we tested the variability in editing levels of non-
recoding sites. In particular, we focused on editing tar-
gets within the primate-specific Alu repeats which con-
stitute the vast majority of editing sites in the human
genome. In this category we looked at a single editing
site in 3 targets selected from the RNA editing database
[18]: FYN (last intron, chr6:112,094,677; (hg18)),
Figure 1 Highly regulated A-to-I RNA-editing within coding
sequences and Alu repeats in human skin samples. 32 skin
samples were tested for editing levels in one site within the coding
regions of FLNA, CYFIP2 and BLCAP and within Alu repeat residing in
the FYN, KLRD1 and CARD11 genes. A. Consistent editing levels in
FLNA, CYFIP2 and BLCAP among different individuals. B. Consistent
Alu A-to-I RNA-editing levels in FYN, KLRD1 and CARD11. C. Mean
editing level of the six sites ± one standard deviation.
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Page 2 of 6CARD11 (the 14th intron, chr7:2,942,082), and KLRD1
(3’ UTR, chr12:10,359,728). Using Sequenom analysis of
the above 32 skin samples, we found low average editing
levels in these sites, 19, 2, and 3% (with standard devia-
tions of 11, 3 and 3) for FYN, KLRD1 and CARD11,
respectively (Figure 1B, C). In order to quantify the
degree of consistency among individuals, we compared
the individual editing levels of the 6 different sites in the
FLNA, CYFIP2, BLCAP, KLRD1, CARD11 and FYN
genes. A statistically significant difference (p < 0.05 by
Mann-Whitney test) between editing levels of the differ-
ent sites was observed for 13 out of the 15 pairs of edit-
ing sites tested (see supplementary Table 1). We
therefore conclude that the variation of results across
individuals is significantly lower than the difference in
editing efficiency between different sites (F-ratio 41.8 by
ANOVA analysis; p-value 1.1E-28).
Most editing sites in the human transcriptome occur
in clusters where a number of nearby sites undergo
editing. Therefore, the question arises whether editing
regulation occurs at the cluster level or at the site
level. That is, whether regulation is able to distinct
editing sites residing in the same highly-edited region.
To answer this question, we direct sequenced an Alu
repeat within the last intron of the FYN gene for 32
different human skin samples and analyzed 7 different
editing sites in this region (see Additional file 1).
Twenty two of the samples resulted in high-quality
sequence data. Distinct editing levels were found for
the 7 sites (Figure 2). Mann-Whitney analysis showed
the editing levels of different sites to be distinct: 20
out of 21 comparisons resulted in a significant (p <
0.05, supplementary Table 2) difference. ANOVA ana-
lysis resulted in F-ratio 68.25 (p = 4.9E-40), demon-
strating that the difference in editing efficiency among
various sites in the same Alu repeat is an order of
magnitude larger than variability in editing efficiency
of specific sites across individuals.
Comparison of editing levels in different tissues
It is established that editing levels are particularly high
in some tissues, including the brain [33]. This can be
attributed to the elevated level of ADAR2 in the brain.
Here we aim at comparing the editing levels in a num-
ber of non-brain tissues. For this purpose we analyzed
editing data [18] for clusters of editing sites in the
3’UTR Alu sequences of 3 different genes: MDM4,
NRIP3 and THOC5 (see Additional file 1) in the follow-
ing tissues: lung, kidney, prostate, uterus, liver and
glioma tumor (not including normal brain tissue). We
found low variability among different tissues and a clear
distinction between different editing sites of the 3 genes.
That is, given the six values of editing levels in the six
non-brain tissues, for two different sites within the same
Alu repeat, the tissue-to-tissue variance is low enough
to allow one to tell (using a standard statistical test, e.g.
t-test or Mann-Whitney) that the two sets of six mea-
surements describe two sites differing in their editing
efficiency. The tissue-to-tissue similarity is high enough
to allow pair-wise distinction between different sites in a
cluster in 51/91, 148/300 and 50/105 of the pairs, in
MDM4, NRIP3 and THOC5, respectively (p < 0.05;
Mann-Whitney test. supplementary tables 3-5). ANOVA
analysis yielded F-ratios 12.71, 18.20 and 5.29 (p-values
7.5E-16, 1.4E-26 and 4.7E-07) for MDM4, NRIP3 and
THOC5, respectively, again showing that the tissue-to-
tissue variability is an order of magnitude lower than
the site-to-site variability within the same cluster. The
standard-deviation to mean ratio is 0.34, 0.49 and 0.62
for MDM4, NRIP3 and THOC5 (averaged over all sites
in the same gene).
Regulated editing events might be recruited for func-
tional processes. As an example, we studied the Alu
editing in the NARF gene. In this gene, insertion of Alu
retrotransposon pair into an intron led to editing of the
Alu repeats, which in turn created a novel primate-spe-
cific alternatively spliced exon [34]. We looked at the
tissue-to-tissue consistency of the editing levels in 5 dif-
ferent sites within this Alu using the data published by
Lev-Maor et al [34]. In concordance with our previous
data, the editing levels of NARF were highly consistent
among different human tissues including transformed
Figure 2 Editing levels of specific sites in a highly-edited
region of FYN is consistent among individual human skin
tissues. A. Editing levels for sites in a highly-edited region of FYN
are presented for 22 skin samples. Site-specific editing levels are
consistent among the samples. B. Editing level and variance of the
seven tested sites of FYN. Mean editing level of the seven sites ±
one standard deviation.
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SKOV3 and MDA, Figure 3): statistically significant dif-
ference (p < 0.05) was observed in 9/10 comparisons
(supplementary table 6). ANOVA analysis yields an F-
ratio 182.6 (p = 7.39E-33), demonstrating once more the
individual to individual scatter to be much lower than
editing-efficiency variability.
Discussion
Our findings demonstrate that editing levels display low
variability among different human individuals not only
in coding but also in the non-coding, non-conserved,
Alu sequences.
RNA Editing of several evolutionary-conserved recod-
ing sites is known to be of critical importance to proper
cell development and function. Altered editing patterns
in these sites are associated with severe phenotypes
[4,8,35]. It is therefore not surprising to find that editing
levels in these sites are uniform among individuals, sug-
gesting tight regulation as one would expect. The three
newly discovered recoding sites considered in this work
are also extremely well evolutionary conserved, and it is
thus reasonable to believe th a tt h e ya l s oh a v eac r i t i c a l
role, yet to be explored. Consistently, we found that
they also all have low variability of editing levels.
Virtually all A-to-I editing events in primates occur in
the primate-specific Alu repeats, and are therefore not
conserved among many species. The biological impor-
tance of these sites, if any, is yet to be shown. We there-
fore tested the consistency of editing levels in these sites
in order to obtain a hint as to their potential role. Edit-
ing events of sites with highly variable levels among
individuals are unlikely to serve as an important link in
a chain of events being part of a biological pathway. The
other side of the coin is that sites whose editing exhibit
a consistent pattern in terms of editing levels might
have been recruited in the course of evolution to serve a
functional role. Surprisingly, we found that editing levels
in sites with Alu repeats do present us with such consis-
tent patterns. The variability among sites, including
neighboring ones, is very high: where some sites show
an extremely low level of a few percent, neighboring
sites could be edited up to 60-80%. Yet, these seemingly
fluctuating patterns are actually consistent among indi-
viduals - strong sites are strong in all samples and weak
site are weak in all samples.
As all sites are edited by the same ADAR enzymes,
what could be the mechanism providing the wide range
of efficiencies on one hand, together with significant
consistency on the other? We propose that A to I edit-
ing is subjected to two levels of control - ADAR expres-
sion and structural patterns of the dsRNA. The essential
ADARs enzymes are expected to be tightly regulated to
have consistent levels among different individuals.
Indeed, it was found that editing enzymes are tightly
regulated during development [25,36]. Here too, we
found ADAR1 levels to be consistent, in most cases,
between different individuals, supporting this assump-
tion (see Additional file 1). Therefore, although the rela-
tion between editing levels and ADARs expression is
probably not a simple linear one [12,25,31], it is likely
that ADAR expression controls editing level. However,
given a certain level of the ADAR enzymes, it seems
likely that sequence and structural differences between
sites determine their editing efficiency relative to other
sites. The sequence and the resulting dsRNA structure
formed by Alu, vary significantly from site to site, but
are shared by all samples. Sequence analysis [37,38]of
editing sites revealed a number of weak motifs. How-
ever, these alone cannot account for the observed
tightly-regulated editing profiles. It is therefore plausible
t h a ts t r u c t u r a lm o t i f sm a yt a k ear o l ea n ds h o u l db e
analyzed as well.
The massive expansion of the Alu repeats in the pri-
mate genome has increased by order of magnitudes the
amount of A-to-I editing in their transcriptome. The
above analysis suggests that this phenomenon provided
the primates with thousands of well-controlled and con-
sistent transcriptomic “switches” that can be utilized for
biological functions. It is not clear how many of these
were actually adopted. One distinct example is the
adoption of editing site in the NARF gene to create a
new editing-assisted splicing event, resulting in a whole-
new primate-specific alternatively-spliced exon [23]. The
surprising consistency shown in editing of arbitrarily
chosen sites within Alu’s tantalizes us to wonder
whether this mechanism of increasing diversification by
creating new editing-assisted splicing events, could be
more widespread. Of particular interest are miRNA tar-
get sites within Alu repeats [39,40], where one can
Figure 3 Editing levels in the NARF gene are regulated among
different tissues and cell-lines. Data from Lev-Maor et al [34] was
analyzed. Editing frequencies of five A-to-I editing sites within the
Alu repeat in the 8
th exon of NARF are shown for 13 different tissues
and cell-lines.
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might result in an efficient mechanism affecting the
translation rate of the harboring gene.
Conclusion
In summary, we show that editing events within Alu
sequences exhibit a consistent pattern of editing levels
across individuals. This might be attributed to sequence
and structural motifs controlling the editing efficiency.
Therefore, Alu intervention in the genome provides the
primates with thousands of well controlled binary tran-
scriptomic switches [41], available for use as additional
regulatory mechanisms. Evidence for sporadic use of
these switches already exists, but it is yet unclear how
widespread this phenomenon is. As A-to-I editing is
most abundant in the brain, the fascinating question
than arises whether the above-mentioned mechanism
might have played a role in primates’ brain evolution.
Methods
Human skin tissues
The study was approved by the Institutional Helsinki
Committee at Sheba Medical Center, Tel Hashomer,
Israel and informed consent was properly obtained by all
participants. Human skin tissues were frozen by liquid
n i t r o g e na f t e rt h e i rr e m o v a la ts u r g e r ya n dk e p ta t- 7 0 ° C
until further use. Thirty two skin samples were tested; 20
inflammatory skin lesions with the following clinical and
pathological diagnoses: Atopic/nummular Dermatitis n =
7, Drug eruption n = 2, Psoriasis n = 1, Allergic contact
dermatitis n = 1 and Cutaneus T-cell Lymphoma (Myco-
sis Fungoides) n = 9. 12 Normal skin samples were col-
lected at the Chaim Sheba Medical Center.
RNA purification, reverse transcription (RT) and A-to-I
RNA editing reading
Total RNA was isolated using TRIzol reagent (Invitro-
gen) according to the manufacturer’s instructions.
Random-primed cDNA synthesis was done on 2 μgo f
total RNA using M-MLV reverse transcriptase (Invitro-
gen) according to the manufacturer’s instructions. For
analyzing editing levels we used Sequenom (San Diego,
CA) MassARRAY Compact Analyzer and MassARRAY
Assay Design 2 software, as described before [32]. The
primer sequences and reaction conditions are available
as supplementary data (Additional file 1).
Direct sequencing and A-to-I editing reading of Alu
In order to compare editing levels of different sites in a
highly edited region within an Alu repeat, we direct
sequenced the 3’ UTR of FYN transcripts. PCR reaction
for cDNA products was carried out using 100 ng (1 l)
of cDNA obtained as described above, at an annealing
temperature of 60°C. The PCR product was separated
by 1.5% agarose gel electrophoresis, and extracted using
QiaQuick gel extraction kit (QIAGEN) and according to
the manufacturer’s instructions. cDNA sequencing was
carried out in genetic analyzer 3100 (Applied Biosys-
tems/Hitachi; Foster City, CA), and according to the
manufacturer’s sequencing protocol. High-quality
sequences were analyzed. Sequencing results were read
using Sequencher 4.2 software (1991-2004 Gene Codes
Corp., Ann Arbor, MI); editing quantification was car-
ried out using DS gene 1.5 software (Accelerys Inc. Dis-
covery Studio 2003; San Diego, CA).
Reference Human Genome version used in the research
Mar. 2006 (hg18) assembly
Additional material
Additional file 1: Supplementary information. This file includes
supplementary tables and figures, primers that have been used and
detailed information about ADAR1 expression results.
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